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Abstract
Individuals conceived by in vitro fertilization (IVF) may be at increased risk of cardio-metabolic disorders. We recently
reported that IVF conceived male mice displayed impaired glucose metabolism at normal and high body weights. In this
study, we examined glucose metabolism in mature female C57BL/6J mice that were conceived by natural conception (NC),
by ovarian stimulation (OS) or by IVF following chow or high-fat diet (HFD) for 8 weeks. By design, litter size was comparable
between groups, but interestingly the birth weight of IVF and OS females was lower than NC females (p#0.001). Mature IVF
female mice displayed increased fasting glucose as compared to NC and OS mice, irrespective of diet. Mature IVF and OS
mice were also more susceptible to the metabolic consequences of high fat diet as compared with NC females, with
impaired glucose tolerance (p#0.01), whereas peripheral insulin resistance and increased hepatic expression of
gluconeogenic genes Ppargc1a, Pck1 and G6pc was observed in IVF mice only (p,0.05). This study suggests that ovarian
stimulation alone and IVF program distinct metabolic effects in females, but that high fat diet may be required to unmask
these effects. This study adds to the growing body of literature that assisted reproduction procedures may increase the risk
of developing type 2 diabetes in an obesity prone environment.
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Introduction
Adverse prenatal environments are linked to the development of
cardiovascular disease and type 2 diabetes in adult human, rodent
and sheep offspring [1–4]. In particular, maternal low protein diets
fed exclusively during the preimplantation period, resulted in
hypertension in mature rats [5,6] and mice [7], as well as
cardiovascular dysfunction in mature sheep [8]. In vitro fertiliza-
tion (IVF) exposes the preimplantation embryo to a non-
physiological environment during embryo culture, and has been
associated with changes in embryo growth and development in
animal models and humans [9,10]. An increased risk of metabolic
and cardiovascular disease has also been shown in some cohorts of
IVF children [11–14] and is documented in mouse models [15–
17]. We have recently demonstrated insulin resistance in a small
cohort of IVF-conceived young adult men and women, and also
showed that these individuals were more susceptible to adverse
outcomes of short-term high fat overfeeding versus naturally
conceived controls [18]. Similarly, we observed that mature IVF
male mice displayed impaired glucose tolerance, under chow and
high fat fed conditions [18].
Evidence from humans and animal models shows that male
embryos grow faster than female embryos [19], and metabolic
differences are generally more profound in male than female
offspring in response to an adverse periconceptional maternal
environment [4,20]. However, a previous mouse study [16]
reported that IVF female offspring were glucose intolerant, but
males maintained normal glucose tolerance, although both sexes
displayed evidence of insulin resistance.
The process of IVF generally involves not only embryo culture,
but ovarian hyperstimulation (OS), which itself has been associated
with poorer perinatal outcomes, including low birth weight and
preterm birth [21–23]. One study showed that 4-year-old children
conceived following stimulated IVF had higher systolic blood
pressure versus 4 year IVF children conceived following
unstimulated or ‘natural IVF’ [24]. This study suggests the process
of ovarian stimulation may be responsible for at least some of the
phenotypes, however these differences may also have been related
to the genetics or subfertility of the parent/s. In mature male mice,
we recently showed that poor fetal growth could be attributed to
ovarian stimulation since birth weight was lower in both OS and
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IVF groups, but that differences in glucose metabolism were
evident solely in mice generated by IVF and not OS alone [18].
The aim of the current study was to examine whether mature
female C57BL/6J mice conceived by IVF or by ovarian
stimulation alone have differences in birth weights or glucose
metabolism as compared with naturally conceived female mice
following chow or high fat diet (HFD) for 8 weeks.
Materials and Methods
Mice
C57BL/6J male and female mice were obtained at 6 weeks of
age, and vasectomized (CBA X C57BL/6) F1 male mice were
obtained at 8 weeks of age from the Animal Resource Centre
(Perth, Western Australia). (CBA X C57BL/6) F1 female mice
were obtained at 6 weeks of age from the University of Adelaide
Laboratory Animal Services (Adelaide, South Australia). All mice
were maintained at 24uC on a 12 h light, 12 h dark cycle, with
standard rodent chow diet with 20% of calories from fat, 16% of
calories from protein, and 64% of calories from carbohydrate
(SF06-105, Specialty Feeds, Glen Forrest, Australia) and water
available ad libitum. All mice were acclimatised for 2 weeks on
chow before experimentation. All experiments were approved by
the University of Adelaide Animal Ethics Committee (Permit
Number: M-2011-248) and were conducted in accordance with
the Australian Code of Practice for the Care and Use of Animals
for Scientific Purposes. All surgeries were performed under
Avertin anesthesia, and all efforts were made to minimize
suffering.
Generating blastocysts
Mouse blastocysts were generated by natural conception (NC
group), or by ovarian hormonal stimulation followed by either
mating (OS group) or by IVF and embryo culture (IVF group) as
reported [18]. For the NC group, female C57BL/6J mice were
placed with male C57BL/6J mice overnight. For the OS group,
female C57BL/6J mice were superovulated with intraperitoneal
injections of 7.5 IU equine chorionic gonadotropin (Calbiochem,
San Diego, CA) followed by 7.5 IU human chorionic gonadotro-
pin (hCG; Calbiochem) 48 h later. Hormone dosages for
hyperovulation in mouse strains range from 2.5 to 10 IU [25],
and7.5 IU was selected in this study following testing for the
optimal dose and as reported previously [26]. After injection with
hCG, these females were placed with male C57BL/6J mice
overnight. The following morning, female mice (NC and OS
groups) with the presence of vaginal plugs were considered
pregnant and were humanely sacrificed by cervical dislocation 3
days later. Blastocysts were collected by flushing dissected uteri
with pre-warmed HEPES-buffered minimal essential medium
(Invitrogen Australia Pty. Ltd.) supplemented with 5 mg/ml
human serum albumin (SAGE Media ART-3001, CooperSurgi-
cal, USA). Blastocysts from the NC and the OS group were placed
in Research Vitro Cleave Media (Cook Medical; QLD, Australia)
for no more than 1 hour prior to being transferred to uteri of
pseudopregnant mice (see below).
For the IVF group, the ovarian stimulation protocol was the
same as for the OS group. In vitro fertilization was performed
using a modified version of that described previously [27]. At 13
hours after injection with hCG, female C57BL/6J mice were
humanely killed by cervical dislocation. Cumulus-oocyte com-
plexes were placed in Research Vitro Fertilization Media (Cook
Medical; QLD, Australia) under paraffin oil (Calbiochem) and
incubated in a modular incubator chamber at 37uC in 6% CO2,
5% O2, 89% N2 for 5–6 hours with sperm, collected from the
cauda epidydimis of male C57BL/6J mice, that had been
previously incubated for 1 hour in Research Vitro Fertilization
Media (Cook Medical; QLD, Australia) for capacitation. Putative
zygotes were placed in Research Vitro Cleave Media (10 zygotes/
20 ml drop; Cook Medical; QLD, Australia) and checked for
fertilization/cleavage the next morning. Embryos (2-cell) were
then transferred to a new drop of Research Vitro Cleave Media
(Cook Medical; QLD, Australia) and cultured in the modular
incubator chamber at 37uC in 6% CO2, 5% O2, 89% N2 for a
further 2 days to the blastocyst stage (90–96 hours post-hCG
injection).
Blastocysts transfer
Sterility of vasectomized (CBA X C57BL/6) F1 males was
confirmed by mating them three times with superovulated (CBA X
C57BL/6) F1 females and verifying the absence of embryos in the
reproductive tract three days later. To generate pseudopregnant
recipient females for embryo transfer, unstimulated (CBA X
C57BL/6) F1 female mice were mated with vasectomized (CBA X
C57BL/6) F1 male mice and those with copulatory plugs the next
morning were considered as day 0.5 of pseudopregnancy. At day
2.5 of pseudopregnancy, totally 7 to 10 blastocysts were
transferred to uteri (3–5 blastocysts/horn) of each pseudopregnant
mouse anesthetized by i.p. injection of Avertin (0.5 mg/g body
weight, Sigma-Aldrich, St. Louis, MO). Analgesia Carprofen
(5 mg/kg) (Rimadyl Pfizer) was injected subcutaneously once after
the surgery.
Pups and diets
Pups were born on day 19.5 of pregnancy and birth weights
measured the next morning. Body weights of pups were measured
weekly. Growth rate was calculated as described previously [28].
Pups were weaned at 3 weeks of age onto chow diet or high-fat
diet (HFD) for 8 weeks. High-fat diet was made in house using the
same recipe as D12492 of Research Diets (New Brunswick, NJ);
60% energy from fat with 91% lard and 9% soybean oil, 20%
energy from protein, and 20% energy from carbohydrate. Only
one or two female offspring were taken from each litter and were
examined for separate tests below in this study.
Glucose and insulin tolerance tests
At 11 weeks of age, mice (n = 6–8) were fasted for 6 hours (from
8 am to 2 pm) and were then challenged with either an
intraperitoneal injection of glucose (2 g/kg) or insulin (Actrapid,
0.75 U/kg, Novo Nordisk Australasia) for glucose or insulin
tolerance tests respectively. Blood samples were obtained from the
tail tip for assessment of glucose at 0, 15, 30, 60, 120 minutes with
a glucometer (AccuChek Performa Monitor, Roche Diagnostics,
Indianapolis, USA), and for insulin assays at 0, 30, 60,
120 minutes during glucose tests only by ultra-sensitive ELISA
kits (Millipore). At 12 weeks of age, mice were sacrificed by
cervical dislocation; inguinal fat, parametrial fat, quadriceps and
liver were immediately excised and snap-frozen. Tissue samples
were frozen at 280uC for later assessment.
Quantitative real-time PCR
Total RNA (n= 6) was extracted from liver and quadriceps
using Trizol (Invitrogen, USA) following manufacturer’s instruc-
tions. The concentration and purity of RNA were determined by
Nanodrop (Thermo Fisher Scientific, California, USA). cDNA was
synthesized from 1 mg of each RNA sample in 20 ml reactions
using the QuantiTect reverse transcription kit (Qiagen, Valencia,
CA). Standard control samples (25 ng/ml) pooled from each
Metabolic Phenotyping of Female Mice Born by IVF
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cDNA sample were diluted to create a standard curve as described
previously [29].
Quantitative real-time PCR was performed as described
previously [29] in duplicate with the ABI 7500 sequence detection
system (Applied Biosystems, Foster City, CA) using TaqMan Fast
Universal Master Mix and TaqMan primers and probes listed in
Table S1. These genes are key regulators of mitochondrial
biogenesis Ppargc1a (peroxisome proliferator-activated receptor
gamma, coactivator 1 alpha), Ndufb5 (NADH dehydrogenase
(ubiquinone) 1 beta subcomplex, 5) and Tfam (Mitochondrial
transcription factor A), lipid metabolism Srebf1 (Sterol regulatory
element-binding transcription factor 1) and Cpt1a (carnitine
palmitoyltransferase 1A), and glucose metabolism Gck (Glucoki-
nase), G6pc (Glucose-6-phosphatase catalytic subunit) and Pck1
(phosphoenolpyruvate carboxykinase 1, cytosolic). The NormFin-
der program was used as described previously [30] and Hprt
(Hypoxanthine phosphoribosyltransferase) and Ppia (Cyclophilin-
A) out of 7 potential reference genes were identified as the best
combination of reference genes. Data were analyzed using the
22(DDCT) method and expressed as the fold change relative to a
control sample, which was selected from the NC group fed on
chow and was included in each run.
Western immunoblotting
Liver and quadriceps (n = 4) were lysed and protein concentra-
tion was determined by bicinchoninic acid assay (Pierce BCA
Protein Assay Kit, Thermo Scientific). Lysates (20 mg protein)
were resolved by SDS-PAGE (Criterion XT 10% Bis Tris precast
gels, Bio-Rad, Australia) and transferred onto PVDF membranes
(criterion gel blotting sandwiches, Bio-Rad, Australia). Membranes
were blocked in Tris-buffered saline with Tween 20 (TBST)
[10 mM Tris, 150 Mm NaCl, and 0.1% Tween 20 (pH 7.5)]
containing 5% (wt/vol) Amersham ECL blocking agent (GE
Healthcare Australia Pty. Ltd., NSW, Australia) for 1 hour at
room temperature. Membranes were then incubated with primary
antibodies overnight at 4uC in 5% bovine serum albumin/TBST.
Primary antibodies used were PPARGC1A antibody at 1:1000
(Abcam, MA, USA, Cat. No ab54481) and Total OXPHOS
(oxidative phosphorylation) antibody cocktail at 1:1000 (Abcam,
Cat. No ab110413). Beta-tubulin antibody at 1:1000 (Cell
Signaling, Cat. No 2146) was used as reference protein. Mem-
branes were then washed in TBST and incubated with sheep anti-
rabbit IgG alkaline phosphatase conjugated secondary antibody at
1:2500 (Millipore, Temecula, CA) or goat anti-mouse IgG alkaline
phosphatase conjugated secondary antibody at 1:2000 (Millipore,
Temecula, CA) for 1 hour. ECF substrate (GE Healthcare) was
prepared and applied to the blots and then all blots were scanned
for fluorescence by the Typhoon Trio+ (GE Healthcare) following
the manufacturer’s instructions. The band intensity was measured
using Image J software (The National Institutes of Health, USA).
Mitochondrial DNA (mtDNA) copy number quantification
DNA were extracted from quadriceps (10 mg) using a QIAamp
DNA Micro Kit (Qiagen) following manufacturer’s instructions.
The concentration and purity of DNA were determined by
Nanodrop (Thermo Fisher Scientific). DNA was then used to
estimate average mtDNA copy number/cell as described in [31].
The primers for amplification of the mitochondrial gene (12S
rRNA) were 59-CGT TAG GTC AAG GTG TAG CC-39 and 59-
CCA GAC ACA CTT TCC AGT ATG-39. The primers for
amplification of the nuclear gene (b-actin) were 59-GGAAAA-
GAGCCTCAGGGCAT-39 and 59-CTGCCTGACGGCCAGG-
39. PCR amplification of mitochondrial DNA and nuclear DNA
was performed simultaneously in each sample in triplicate using
SYBR Green PCR Master Mix (Applied Biosystems) and a Rotor-
Gene 6000 (Corbett, Valencia, CA) real-time rotary analyzer. The
Ct value for b-actin was subtracted from that for 12S rRNA to
give the DCt value and mtDNA copy number per nuclear genome
(two actin gene copies) is calculated as 2622(DCt).
Statistical analysis
Data are shown as mean 6 the standard error of the mean,
unless otherwise stated. Data were analyzed statistically with SPSS
20 (SPSS, Chicago, IL, USA) and log-transformed for analysis if
not normally distributed. Area under the curve(AUC) for glucose
and insulin was calculated using the trapezoidal rule [32]. Total
OXPHOS protein levels were calculated as the mean of
OXPHOS complexes I–V and the relative density of PPARGC1A
and total OXPHOS was normalized by beta-tubulin. Single
comparisons were performed with one-way ANOVA for treatment
effect or two-way ANOVA with diet and treatment as between
group factors, whereas time-courses were analyzed by repeated-
measures ANOVA and Bonferroni post hoc analysis. Insulin
sensitivity assessed by insulin tolerance test is represented by delta
glucose levels between baseline (0 minute) and 15 minutes and
analyzed by two-way ANOVA, adjusting for baseline glucose
levels which were significantly different between groups and were
related to the change in glucose. Nonparametric tests (Mann-
Whitney U test or Kruskal-Wallis test) were used when required.
Chi square tests were used for nominal data. Differences were
considered statistically significant at P,0.05.
Results
Reduced fetal growth and postnatal catch-up growth in
OS and IVF mice
Litter size and sex ratio were not different between groups (Both
P= 0.5, Table 1). Despite this, birth weight was significantly lower
in the IVF and OS versus the NC female pups (P#0.001,
Table 1). This difference in body weight was maintained in the
IVF female pups until weaning (P= 0.04, Figure 1A), whereas the
OS pups displayed rapid catch-up growth as shown by increased
growth rate as compared with the NC pups at 1 week (P = 0.004;
Figure 1 A,B). After weaning, a significantly increased growth rate
was observed at 4 weeks of age in IVF vs NC females fed a chow
diet and at 8 weeks of age in IVF vs NC and OS females fed a
HFD (P,0.04, Figure1 D,F). OS mice weighed significantly less
than IVF and NC mice from 4 weeks after exposure to HFD (P,
0.01, Figure 1E). In a subset of animals (n = 4/group), liver weight
and adipose tissue fat pads were weighed. As expected, the liver
weight ratio was decreased and adipose tissue weight ratio
increased in mice that were fed a HFD (P,0.001, Figure S1).
However, a significantly higher percentage of body weight was in
the inguinal and parametrial fat pads in OS and IVF versus NC
mice fed HFD (P#0.001, Figure S1).
Impaired glucose metabolism in OS and IVF female mice
following HFD
Fasting glucose was significantly higher in IVF versus NC and
OS mice, independently of diet (P,0.05, Figure 2A). However, no
other different phenotypes were noted in IVF or OS females
versus NC females fed a chow diet. HFD increased fasting glucose,
fasting insulin, glucose area under curve (AUC), insulin AUC and
reduced insulin sensitivity (diet effect, P,0.05, Figure 2) and OS
and IVF mice were more susceptible to adverse effects of HFD as
evidenced by impaired glucose tolerance versus NC mice (P#0.01,
Figure 2E). Insulin sensitivity as assessed by insulin tolerance test
was also significantly lower in IVF mice versus NC mice only at
Metabolic Phenotyping of Female Mice Born by IVF
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15 minutes (P,0.001, Figure 2K). Lower fasting insulin (P= 0.03,
Figure 2B) and lower insulin AUC was observed in OS mice as
compared with NC and IVF mice in response to glucose tolerance
test (P,0.05, Figure 2H).
We also examined the mRNA expression of genes involved in
glucose and lipid metabolism in liver. HFD increased the
expression of the genes Srebf1, Cpt1a, Ppargc1a, Tfam, and
Gck, but not gluconeogenic genes Pck1 and G6pc (Figure 3).
Significant differences were also noted between groups, with
increased hepatic expression of Ppargc1a and Pck1 in IVF mice
and decreased expression of Cpt1a in OS mice, independently of
diet. The expression of G6pc and Tfam was also higher in IVF
versus NC or OS mice respectively (Figure 3). However, no
difference was observed in protein levels of mitochondrial
biogenesis markers PPARGC1A and total OXPHOS in liver
(Figure 4). These genes were also assessed in quadriceps muscle
from animals fed HFD. No difference was observed in either gene
expression or mitochondrial DNA copy number or protein levels
of these makers in quadriceps muscle (data not shown).
Discussion
Children conceived by IVF have some evidence of altered
cardio-metabolic outcomes [14,33]. We recently showed that IVF
young adult humans displayed peripheral insulin resistance [18],
an early risk factor in the development of type 2 diabetes [34,35],
and significantly greater increases in systolic blood pressure when
exposed to a high fat overfeeding diet for 3 days [18].
Furthermore, we showed that male C57BL6/J mice conceived
by IVF displayed hyperglycemia and impaired glucose tolerance
when fed chow or HFD [18]. In this study, we now report that
female mice conceived by IVF also exhibited higher fasting glucose
levels, independently of diet. However, IVF female mice fed a
chow diet did not display any other adverse risk factors, whereas
impaired glucose tolerance was unmasked by HFD, but this was
apparent in both IVF and OS females. This study suggests that
manipulation of the preimplantation embryo may predispose
mature female mice to increased risk of developing type 2 diabetes,
in an obesogenic environment.
In this study, birth weight was lower in female mice conceived
either by ovarian stimulation alone or by IVF. This is consistent
with the results we have recently reported in male mice [18].
Figure 1. Body weight and growth rate in female mice offspring. Specific growth rate was calculated as follow: (Wn2W(n21)/W(n21). W is
body weight, and n is age in weeks. (A), *IVF vs NC, P = 0.04; (n = 21–26). (B), *OS vs NC, P = 0.004; #IVF vs OS, P = 0.006. (n = 21–26). (D), Chow: *IVF vs
NC, P = 0.03. (E), HFD: #IVF vs OS, P,0.001; *IVF & NC vs OS; P,0.01. (F), HFD: #IVF vs OS & NC, P,0.01.
doi:10.1371/journal.pone.0113155.g001
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Lower fetal weights have also been reported in mice conceived
following ovarian stimulation at day 14 and day 18 of gestation
[36,37]. Lower birth weights are also reported in human infants
conceived by ovarian stimulation alone or by IVF after either fresh
or frozen embryo transfer as compared with naturally conceived
infants [21,22,38–43], although fresh embryo transfer further
increases the risk of low birth weight and preterm birth in human
infants as compared with frozen-thaw embryo transfer cycles
[40,42,43]. In this study, while female donor mice for both the IVF
and OS groups underwent ovarian hyperstimulation, the blasto-
cysts for the OS group were developed in a hormonally stimulated
reproductive tract prior to transfer, whereas the IVF blastocysts
were developed in vitro in culture media prior to transfer.
Previous studies have shown that both stimulated oviductal and
in vitro culture environments are suboptimal and can impair
embryo and fetal development in mice [44,45].The mechanism
underlying the association between ovarian stimulation and low
birth weight was not a focus of this study. However, since the
embryos were transferred to unstimulated recipients in this study,
this suggests that differences may be due to impaired oocyte
quality and/or subsequent embryonic and fetal development,
rather than changes in endometrial receptivity [36,37,44,46].
Further study is needed to determine if lower doses of
gonadotropin result in less severe phenotypes in C57BL/6J mice
and whether the OS phenotype is altered if kept in the stimulated
uterine environment rather than undergoing embryo transfer.
Accelerated postnatal catch-up growth in infancy and early
childhood are independent risk factors for cardiovascular disease
and type 2 diabetes in humans [1,2,47–51] and rodents [52–54].
Accelerated weight gain in late infancy has been reported in IVF
children as compared with spontaneously conceived children born
to subfertile parents, and early childhood growth was also related
to increased blood pressure in IVF children [55]. In this study,
both OS and IVF female pups displayed catch-up growth. Of
note, catch-up growth was observed in OS females soon after birth
but occurred much later in IVF females after weaning, and OS
mice on HFD failed to maintain this increase after 4 weeks on
HFD. Sequential assessments of growth axis factors such as growth
hormone, IGF, and ghrelin are needed during the early growth
phase to tease out potential mechanisms underlying these
differences in weight gain. Interestingly, and unlike our findings
in males [18], both OS and IVF females fed on HFD displayed
relatively higher adiposity, although this was only examined in 4
animals per group and thus should be confirmed with greater
numbers and by other assessments of body composition. Further,
assessments of food intake and energy metabolism should also be
included in future studies to determine mechanisms underlying
this difference in energy needs between groups. In this study, we
also observed that IVF and OS mice displayed impaired glucose
tolerance following HFD. Scott et al. also reported impaired
glucose tolerance, and a compensatory insulin response to glucose
in IVF versus naturally conceived B6C3F1 female mice at 8 weeks
of age, even in response to chow diet [16]. Two more recent
studies reported no differences in glucose tolerance between chow
fed CF1xB6D2F1 or chow and HFD fed C57BL/6J female mice
conceived by ovarian stimulation alone versus IVF [56,57],
whereas glucose intolerance was observed in IVF females when
embryos were cultured in more stressful conditions as compared
with OS females, but notably these studies did not test relative to
an unstimulated naturally conceived control mouse, as was
performed in this study by including the NC group.
Interestingly, the pathways underlying these differences in
glucose tolerance may be distinct between OS and IVF groups.
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conjunction with lower insulin, possibly indicating impaired b-cell
function. However, we did not collect the pancreas, and thus
cannot assess islet numbers or size, nor investigate the insulin
response to IV or oral GTT. In IVF females fed a HFD,
peripheral insulin resistance as assessed by insulin tolerance test
was noted and likely responsible for the impaired glucose
tolerance. These data supports our previous findings of peripheral
insulin resistance in IVF young adults, of whom 70% were women,
and in this group we did not detect any differences in b-cell
secretory capacity in response to intravenous injection of glucose
[18].
We recently showed that only IVF, and not OS, conceived male
mice displayed impaired glucose intolerance versus NC, and that
this was observed following either chow or HFD [18]. This
difference between sexes indicates that sexual dimorphism may
exist in offspring conceived by IVF. Sex differences in phenotypes
have been identified in several developmental programming
models of adult diseases both in humans and animals [4,20].
Some of these differences may be because males grow faster than
females in utero and thus are more vulnerable to malnutrition
[58]. Furthermore, marked differences in the gene expression
patterns are noted in male and female preimplantation embryos
[59].
Uniquely, higher fasting blood glucose was observed in IVF
females on chow and high fat diet, which we also observed in IVF
males generated from the same litters [18]. We speculate this may
be due to increased hepatic gluconeogenesis, since we observed
increased expression of key gluconeogenic genes including
Ppargc1a, Pck1 and G6pc in the livers of IVF females. Ppargc1ais
a key regulator of hepatic gluconeogenesis that contributes to
circulating hyperglycemia [60], and liver-specific Ppargc1a-
deficient mice have reduced Pck1 and G6pc expression and mild
hypoglycaemia [61]. IVF male mice displayed increased hepatic
expression of key lipogenic gene Srebf1 and impaired hepatic
insulin sensitivity as evidenced by reduced AKT phosphorylation
in liver following an insulin stimulation test [18]. Thus, whilst male
and female IVF offspring both display hyperglycemia, this may be
due to alternative activation of Ppargc1a or Srebf1 pathway[62].
However, this result requires further testing. Importantly, our
findings support previous results in humans that have shown
higher fasting glucose levels in pubertal IVF children that could
not be explained by environmental factors, including parental
subfertility [12]. Taken together, the data suggests that in vitro
culture induces profound alterations of metabolic regulatory
pathways compared to the in vivo hormonally stimulated tract
environment.
Figure 2. Fasting glucose, fasting insulin, glucose (C–E) and insulin (F–H) response to intraperitoneal glucose tolerance tests, and
insulin tolerance tests (I–K) in female mice offspring. AU, arbitrary unit. (A), *IVF vs NC, P = 0.01; IVF vs OS, P = 0.03; **Diet effect, P = 0.01. (B),
*IVF vs OS, P = 0.03; **Diet effect, P = 0.002. (E), *OS vs NC, P = 0.01; IVF vs NC, P,0.001; **Diet effect, P,0.001. (H), *OS vs IVF, P = 0.001,OS vs NC,
P = 0.04; **Diet effect, P,0.001. (I–J), The glucose levels at T0 and T30 following insulin i.p. (K), Insulin sensitivity is represented by delta glucose
adjusting baseline (T0–T15);*IVF vs NC, P,0.001; **Diet effect, P = 0.02. (L), Insulin sensitivity is represented by delta glucose adjusting baseline (T0–
T30); **Diet effect, P = 0.01.
doi:10.1371/journal.pone.0113155.g002
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To our knowledge, only three studies have examined the long
term effects of IVF on glucose metabolism in mouse models to date
[16,56,57]. However, one group did not control for litter size or
genetics between IVF and control groups, which may have
impacted the outcomes. Two more recent studies compared IVF
to models of ovarian stimulation alone [56,57], which we and
others have shown impairs fetal growth, and may also alter
metabolic outcomes [36,37,44,46], and one study utilized outbred
mice, which are less suited for metabolic studies [57]. In this study,
we performed blastocyst transfer in all three groups so that we
could control for any effects of embryo transfer, and more
importantly enabled matching of litter size, as well as maternal
environment across all three groups.
In conclusion, ovarian stimulation reduced fetal growth
in utero, and when coupled with accelerated catch up growth
and HFD, results in adiposity and impaired glucose tolerance.
Further, in vitro culture of embryos uniquely increased fasting
glucose and markers of hepatic gluconeogenesis, suggesting that
IVF in particular, may increase the risk of developing type 2
diabetes in adulthood.
Figure 3. Hepatic gene expression of female mice offspring. White bars represent the NC group, grey bars represent the OS group and black
bars represent the IVF group (n = 6). (A), **Diet effect, P = 0.009. (B), *OS vs IVF & NC, P,0.01; **Diet effect: P,0.001. (C), *IVF vs NC, P = 0.03; IVF vs OS,
P,0.001; **Diet effect, P = 0.005. (D), *IVF vs OS, P = 0.003; **Diet effect, P = 0.003. (E), *IVF vs NC, P = 0.05; IVF vs OS, P = 0.02. (F), *IVF vs NC, P = 0.03.
(G), **Diet effect, P,0.001.
doi:10.1371/journal.pone.0113155.g003
Figure 4. Protein levels of mitochondrial biogenesis markers PPARGC1A and total oxidative phosphorylation (OXPHOS) in liver of
female mice offspring.White bars represent NC group, grey bars represent OS group and black bars represent IVF group (n = 4). (A), representative
blots of PPARGC1A, OXPHOS complexes I–V and beta-tubulin. (B), **Diet effect, P,0.001.
doi:10.1371/journal.pone.0113155.g004
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Supporting Information
Figure S1 Tissue weight ratio (normalized to body
weight) in female mice offspring. **Diet effect, P,0.001.
(A) Liver; (B), Inguinal fat, *OS vs NC, P=0.02; IVF vs NC,
P=0.001; (C), Parametrial fat, *OS vs NC, P= 0.01; IVF vs NC,
P,0.001.
(TIF)
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